| 1 |
33881796 | Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes. | 2021 Aug |
4 |
| 2 |
32317005 | Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus. | 2020 Apr 21 |
1 |
| 3 |
30302966 | Soluble Dipeptidyl Peptidase-4 Levels Are Associated with Decreased Renal Function in Patients with Type 2 Diabetes Mellitus. | 2019 Feb |
2 |
| 4 |
30774748 | Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension. | 2019 |
1 |
| 5 |
31164243 | DPP-4 Inhibitor Dose Selection According to Manufacturer Specifications: A Contemporary Experience From UK General Practice. | 2019 Aug |
2 |
| 6 |
31627406 | Comparing the Effect of Dipeptidyl-Peptidase 4 Inhibitors and Sulfonylureas on Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Prospective Open-Label Study. | 2019 Oct 17 |
5 |
| 7 |
29146035 | Renal outcomes with dipeptidyl peptidase-4 inhibitors. | 2018 Mar |
1 |
| 8 |
30049504 | Prescription of DPP-4 Inhibitors to Patients With Adult Type 2 Diabetes Mellitus and Creatinine Clearance >50 mL/min: The UK Primary Care Experience. | 2018 Aug |
2 |
| 9 |
30087386 | Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery. | 2018 Aug 7 |
1 |
| 10 |
31089516 | Association between Serum Dipeptidyl Peptidase-4 Concentration and Obesity-related Factors in Health Screen Examinees. | 2017 Sep |
1 |
| 11 |
26821795 | Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of diabetic nephropathy in Chinese patients with newly diagnosed type 2 diabetes: A cross-sectional study. | 2016 Mar |
2 |
| 12 |
27321309 | Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitus. | 2016 Jun |
1 |
| 13 |
27402391 | Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment. | 2016 Sep |
1 |
| 14 |
25294850 | Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: a four-year prospective study. | 2015 Mar |
1 |
| 15 |
24684351 | Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment. | 2014 Oct |
1 |
| 16 |
22718884 | DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury. | 2012 Sep |
1 |
| 17 |
18007554 | Dipeptidyl peptidase IV (DDP IV) in NASH patients. | 2007 Oct-Dec |
1 |